Financial Gravity Asset Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12
Closed -$120 1461
2024
Q1
$120 Buy
+12
New +$122 ﹤0.01% 1706
2023
Q3
Sell
-4
Closed -$9 1257
2023
Q2
$9 Buy
+4
New +$18 ﹤0.01% 1548
2023
Q1
Sell
-16
Closed -$43 1140
2022
Q4
$43 Buy
+16
New +$180 ﹤0.01% 1244

Other funds holding ALT

Financial Gravity Asset Management's ALT Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Altimmune (ALT) in Q2 2024, closing a stake of 12 shares — an estimated $120 sold.

Financial Gravity Asset Management first reported a position in ALT in Q4 2022 and held it in 3 quarters. The position peaked at $120 in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 12 Altimmune shares in Q2 2024, an estimated $120.
  • Financial Gravity Asset Management first reported a position in Altimmune in Q4 2022 and held it in 3 quarters.
  • Financial Gravity Asset Management's Altimmune position peaked at $120 in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.